These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32984013)

  • 1. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.
    Chen Z; Dai Y; Huang X; Chen K; Gao Y; Li N; Wang D; Chen A; Yang Q; Hong Y; Zeng S; Mao W
    Front Oncol; 2020; 10():1545. PubMed ID: 32984013
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
    Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
    J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
    Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
    J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
    Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
    Front Oncol; 2022; 12():790933. PubMed ID: 35155234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
    Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
    J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.
    Mir SA; Rajagopalan P; Jain AP; Khan AA; Datta KK; Mohan SV; Lateef SS; Sahasrabuddhe N; Somani BL; Keshava Prasad TS; Chatterjee A; Veerendra Kumar KV; VijayaKumar M; Kumar RV; Gundimeda S; Pandey A; Gowda H
    J Proteomics; 2015 Sep; 127(Pt A):96-102. PubMed ID: 25982385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma.
    Zang B; Wang W; Wang Y; Li P; Xia T; Liu X; Chen D; Piao HL; Qi H; Ma Y
    Front Mol Biosci; 2021; 8():721990. PubMed ID: 34568427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation.
    Chen Z; Huang X; Gao Y; Zeng S; Mao W
    J Pharm Anal; 2021 Aug; 11(4):505-514. PubMed ID: 34513127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
    Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
    J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Di S; Li M; Ma Z; Guo K; Li X; Yan X
    Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma.
    Li C; Wang Q; Ma J; Shi S; Chen X; Yang H; Han J
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28937628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
    Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based study.
    Sun Y; Liu W; Su M; Zhang T; Li X; Liu W; Cai Y; Zhao D; Yang M; Zhu Z; Wang J; Yu J
    Cell Death Discov; 2024 Mar; 10(1):139. PubMed ID: 38485739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.